查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552476

全球结核病诊断市场：到 2033 年的机会和策略

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 353 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018 年全球结核病诊断市值为 17.484 亿美元，到 2023 年复合年增长率将超过 3.0%

核酸检测的采用率有所提高

核酸检测的广泛采用支持了结核病诊断市场的成长。结核菌核酸增幅检查(NAAT) 用于鑑定痰液和其他呼吸道检体中的结核分枝桿菌复合体 (MTBC) DNA（去氧核糖核酸）。与传统显微镜相比，核酸检测具有准确度更高、观察更快的优点。例如，2022年，根据罗德岛州卫生部公布的资料，罗德岛州卫生实验室（RISHL）已能够在呼吸道检体中检测到结核分枝桿菌复合体（MTB-complex）DNA的存在。所使用的自动化分子诊断测试NAAT 利用Cepheid Xpert MTB/RIF 测定。此外，2021 年 2 月，世界卫生组织 (WHO) 发布了用于诊断结核病和抗药性的新分子检测的最新资讯。新技术更新包括用于检测结核病以及利福平和异烟肼抗药性的中等复杂性自动化核酸增幅检查（NAAT）；以及用于检测Pyrazinamide抗药性的基于高复杂性杂合反应的NAAT。因此，核酸检测的日益普及支持了结核病诊断市场的成长。

目录

第一章执行摘要

  • 结核病诊断 - 市场吸引力和宏观经济状况

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章市场特征

  • 一般市场定义
  • 概述
  • 结核病诊断市场定义与细分
  • 市场区隔：按测试类型
    • 放射线检查
    • 核酸检测
    • 细胞激素检测试验
    • 抗药性测试
    • 皮肤测试/曼图测试（TST）
    • 血液检查/血清学检查
    • 涂片显微镜检查
    • 文化测试
    • 其他检查类型
  • 市场区隔：依疾病阶段
    • 潜伏性结核病
    • 活动性结核病
  • 市场区隔：按最终用户
    • 医院和诊断实验室
    • 医生办公室检查室
    • 参考实验室
    • 学术研究设施

第七章 主要市场趋势

  • 用于结核病诊断的次世代定序（NGS）平台
  • 先进诊断解决方案的新产品创新
  • 介绍 T 细胞检测以提高结核病检测的准确性和可靠性
  • 提高基于人工智慧（AI）的结核病诊断的准确性
  • 使用行动装置增强资源有限环境中的存取能力
  • 市场参与者之间的策略合作以增强诊断的可及性
  • 技术进步正在改变结核病检测的面貌
  • 结核病微创检测血液检测简介

第八章结核病诊断市场-宏观经济情景

  • COVID-19 的影响：结核病诊断市场
  • 乌克兰战争的影响：结核病诊断市场
  • 高通膨的影响：结核病诊断市场

第九章世界市场规模与成长

  • 市场规模
  • 2018-2023 年市场成长表现
    • 2018-2023年市场驱动因素
    • 2018-2023年市场限制因素
  • 市场成长预测，2023-2028，2033F
    • 2023-2028年市场驱动因素
    • 2023-2028年市场限制因素

第10章全球结核病诊断市场：细分

  • 全球结核病诊断市场：按测试类型分類的表现和预测，2018-2023、2028F、2033F
  • 全球结核病诊断市场：2018-2023、2028F、2033F分阶段表现与预测
  • 全球结核病诊断市场：最终用户的表现和预测，2018-2023、2028F、2033F

第十一章结核病诊断市场：区域与国家分析

  • 全球结核病诊断市场：按地区分類的表现和预测，2018-2023、2028F、2033F
  • 全球结核病诊断市场：按国家分類的绩效和预测，2018-2023、2028F、2033F

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • 公司简介
  • Becton, Dickinson and Company
  • Qiagen NV
  • F. Hoffman-La Roche Ltd
  • BioMerieux SA
  • Danaher Corporation（Cepheid, Inc.）

第二十章 其他大型创新企业

  • Abbott Laboratories, Inc
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific, Inc
  • PerkinElmer, Inc
  • Bio-Techne Corporation
  • Hologic, Inc
  • Laboratory Corporation
  • Siemens Healthineers
  • Akonni Biosystems Inc
  • Hain Lifescience GmbH
  • Creative Diagnostics
  • Lionex GmbH
  • Genedrive PLC
  • Mylab Discovery Solutions Pvt. Ltd
  • AdvaCare Pharma

第21章 竞争基准化分析

第22章竞争对手仪表板

第二十三章 重大併购

  • Molbio Diagnostics Acquired Prognosys Medical Systems
  • SD Biosensor Acquired Relab
  • Hologic Inc. Acquired Mobidiag Oy
  • PerkinElmer Acquired Oxford Immunotec
  • Thermo Fisher Scientific Acquired Mesa Biotech Inc.

第24章机会与策略

  • 2028 年全球结核病诊断市场：提供新机会的国家
  • 2028 年全球结核病诊断市场：提供新机会的细分市场
  • 2028 年全球结核诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第25章结核病诊断市场：结论与建议

  • 结论
  • 推荐
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第26章附录

简介目录
Product Code: o&s1333

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for tuberculosis (TB) diagnosis. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

TB is an infectious disease that primarily affects the lungs and is caused by the bacterium Mycobacterium tuberculosis. Imaging studies, sputum microscopy, culture and molecular testing are some of the tests and techniques used in TB diagnoses. The purpose of TB diagnostics is to promptly and precisely identify people who have active TB so that they can get the right care and avoid spreading it to others.

The global tuberculosis diagnostics market was valued at $1,748.4 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 3.0%

Rise In The Adoption Of Nucleic Acid Testing

During the historic period, the rise in the adoption of nucleic acid testing supported the growth of the tuberculosis diagnostics market. A nucleic acid amplification test (NAAT) for tuberculosis (TB) is used to identify Mycobacterium tuberculosis complex (MTBC) DNA (deoxyribonucleic acid) in sputum or other respiratory samples. The nucleic acid testing provides benefits such as greater accuracy than conventional microscopy techniques and faster findings. For example, in 2022, according to data published by the State of Rhode Island Department of Health, it has been observed that Rhode Island State Health Laboratory (RISHL) utilizes the Cepheid Xpert MTB/RIF assay for NAAT, an automated molecular diagnostic test that is used to detect the presence of Mycobacterium tuberculosis complex (MTB-complex) DNA in respiratory specimens. Further, in February 2021, the World Health Organization (WHO) announced updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance. The updates on new technologies included moderate complexity automated Nucleic Acid Amplification Tests (NAATs), for detection of TB and resistance to rifampicin and isoniazid, low complexity automated NAATs for detection of resistance to isoniazid and second-line anti-TB agents and high complexity hybridization-based NAATs for detection of resistance to pyrazinamide. Therefore, the rise in the adoption of nucleic acid testing supported the growth of the tuberculosis diagnostics market.

Next Generation Sequencing (NGS) Platforms For TB Diagnostics

The use of next-generation sequencing (NGS) platforms to detect drug-resistant strains of tuberculosis (TB) at a high throughput and with higher speed and accuracy is emerging as a potential trend in TB diagnostics. Companies operating in the tuberculosis diagnostics market are focusing on next generation sequencing platform for rapidly diagnosing drug-resistant tuberculosis. For example, in April 2024, QIAGEN, a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic research and pharmaceutical research, launched the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against tuberculosis (TB), the world's leading infectious disease killer. The QIAseq xHYB Mycobacterium tuberculosis Panel represents a major advancement in solving the problem of bacterial WGS from complex host samples, using next-generation sequencing (NGS). Further, in March 2023, Illumina, a US-based biotechnology company and GenoScreen, a France-based genomics company, introduced a new tuberculosis test that combines products from Illumina with the GenoScreen Deeplex Myc-TB assay, a targeted next-generation sequencing (NGS)-based test for Tuberculosis (TB). This test can detect TB mycobacteria, as well as more than 100 non-TB mycobacterial species.

The global tuberculosis diagnostics market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 28.3% of the total market in 2023.

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tuberculosis diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for tuberculosis diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tuberculosis diagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by test type, by disease stage and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tuberculosis diagnostics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by test type, by disease stage and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for tuberculosis diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
  • 3) By End User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
  • Companies Mentioned: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La Roche AG; bioMerieux SA.; Danaher Corporation (Cepheid, Inc.)
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tuberculosis diagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Tuberculosis Diagnostics - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Tuberculosis Diagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Test Type
    • 6.4.1 Radiographic Test
    • 6.4.2 Nucleic Acid Testing
    • 6.4.3 Cytokine Detection Test
    • 6.4.4 Drug Resistance Test
    • 6.4.5 Skin Test/Mantoux Test (TST)
    • 6.4.6 Blood Test/Serology Test
    • 6.4.7 Smear Microscopy
    • 6.4.8 Cultured-Based Tests
    • 6.4.9 Other Test Types
  • 6.5 Market Segmentation By Disease Stage
    • 6.5.1 Latent Tuberculosis
    • 6.5.2 Active Tuberculosis
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Hospitals And Diagnostic Laboratories
    • 6.6.2 Physician's Office Laboratories
    • 6.6.3 Reference Laboratories
    • 6.6.4 Academics And Research Facilities

7 Major Market Trends

  • 7.1 Next Generation Sequencing (NGS) Platforms For TB Diagnostics
  • 7.2 New Product Innovations For Advanced Diagnostics Solutions
  • 7.3 Introduction Of T Cell Tests To Transform TB Detection With Precision And Reliability
  • 7.4 Artificial Intelligence (AI)-Based Tuberculosis Diagnostics To Enhance Accuracy
  • 7.5 Use Of Portable Devices To Enhance Access In Resource-Limited Settings
  • 7.6 Strategic Collaborations Among Market Players To Enhance Access To Diagnostics
  • 7.7 Technology Advancements To Transform The Landscape Of TB Detection
  • 7.8 Introduction Of Blood-Based Tests For Minimally Invasive Detection Of TB

8 Tuberculosis Diagnostics Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Tuberculosis Diagnostics Market
  • 8.2 Impact Of The War In Ukraine On The Tuberculosis Diagnostics Market
  • 8.3 Impact Of High Inflation On The Tuberculosis Diagnostics Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Tuberculosis Diagnostics Market Segmentation

  • 10.1 Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Tuberculosis Diagnostics Market, Regional and Country Analysis

  • 11.1 Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Tuberculosis Diagnostics Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Tuberculosis Diagnostics Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Tuberculosis Diagnostics Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Tuberculosis Diagnostics Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Becton, Dickinson and Company
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Qiagen N.V.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 F. Hoffman-La Roche Ltd
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 BioMerieux SA
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Danaher Corporation (Cepheid, Inc.)
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • 20.1 Abbott Laboratories, Inc
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Bio-Rad Laboratories, Inc
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 Thermo Fisher Scientific, Inc
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 PerkinElmer, Inc
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Bio-Techne Corporation
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Hologic, Inc
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 Laboratory Corporation
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Siemens Healthineers
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 Akonni Biosystems Inc
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Hain Lifescience GmbH
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Creative Diagnostics
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Lionex GmbH
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Genedrive PLC
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Mylab Discovery Solutions Pvt. Ltd
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 AdvaCare Pharma
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Molbio Diagnostics Acquired Prognosys Medical Systems
  • 23.2 SD Biosensor Acquired Relab
  • 23.3 Hologic Inc. Acquired Mobidiag Oy
  • 23.4 PerkinElmer Acquired Oxford Immunotec
  • 23.5 Thermo Fisher Scientific Acquired Mesa Biotech Inc.

24 Opportunities And Strategies

  • 24.1 Global Tuberculosis Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Tuberculosis Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Tuberculosis Diagnostics Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Tuberculosis Diagnostics Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer